Assignee
TRIPEP AB
SE·31 granted patents·4 pending applications·502 citations·filing 1995–2009
Top patents by PatentIndex Score
35 records- 0196US6469143B2Antigen/antibody specificity exchangerTRIPEP AB·Filed 2001·Granted Oct 22, 2002·44 cites·12 claims
- 0295US6417324B1Synthetic peptides that bind to the hepatitis B virus core and e antigensTRIPEP AB·Filed 2000·Granted Jul 9, 2002·33 cites·15 claims
- 0394US6660842B1Ligand/receptor specificity exchangers that redirect antibodies to receptors on a pathogenTRIPEP AB·Filed 2000·Granted Dec 9, 2003·34 cites·34 claims
- 0494US6245895B1Antigen/antibody specificity exchangerTRIPEP AB·Filed 2000·Granted Jun 12, 2001·30 cites·3 claims
- 0593US7439347B2Hepatitis C virus non-structural NS3/4A fusion geneTRIPEP AB·Filed 2005·Granted Oct 21, 2008·12 cites·70 claims
- 0693US7226912B2Hepatitis C virus non-structural NS3/4A fusion geneTRIPEP AB·Filed 2006·Granted Jun 5, 2007·14 cites·84 claims
- 0793US7223743B2Hepatitis C virus codon optimized non-structural NS3/4A fusion geneTRIPEP AB·Filed 2006·Granted May 29, 2007·13 cites·84 claims
- 0893US6858590B2Vaccines containing ribavirin and methods of use thereofTRIPEP AB·Filed 2001·Granted Feb 22, 2005·36 cites·14 claims
- 0992US6680059B2Vaccines containing ribavirin and methods of use thereofTRIPEP AB·Filed 2002·Granted Jan 20, 2004·38 cites·55 claims
- 1090US7307066B2Hepatitis C virus codon optimized non-structural NS3/4A fusion geneTRIPEP AB·Filed 2005·Granted Dec 11, 2007·9 cites·73 claims
- 1190US6933366B2Specificity exchangers that redirect antibodies to bacterial adhesion receptorsTRIPEP AB·Filed 2003·Granted Aug 23, 2005·19 cites·19 claims
- 1289US7022830B2Hepatitis C virus codon optimized non-structural NS3/4A fusion geneTRIPEP AB·Filed 2002·Granted Apr 4, 2006·17 cites·11 claims
- 1388US6960569B2Hepatitis C virus non-structural NS3/4A fusion geneTRIPEP AB·Filed 2001·Granted Nov 1, 2005·28 cites·50 claims
- 1487US7332166B2Glycosylated specificity exchangersTRIPEP AB·Filed 2006·Granted Feb 19, 2008·6 cites·10 claims
- 1587US7318926B2Glycosylated specificity exchangersTRIPEP AB·Filed 2004·Granted Jan 15, 2008·10 cites·15 claims
- 1686US7638499B2Hepatitis C virus codon optimized non-structural NS3/4A fusion geneTRIPEP AB·Filed 2007·Granted Dec 29, 2009·4 cites·10 claims
- 1786US7241440B2Vaccines containing ribavirin and methods of use thereofTRIPEP AB·Filed 2004·Granted Jul 10, 2007·10 cites·34 claims
- 1886US6040137AAntigen/antibody specification exchangerTRIPEP AB·Filed 1999·Granted Mar 21, 2000·35 cites·18 claims
- 1983US7019111B2Glycosylated ligand/receptor specificity exchangers specific for bacterial adhesion receptorsTRIPEP AB·Filed 2003·Granted Mar 28, 2006·6 cites·21 claims
- 2083US5869232AAntigen/antibody specificity exchangerTRIPEP AB·Filed 1995·Granted Feb 9, 1999·41 cites·17 claims
- 2182US7566812B2Transgenic mouse models of hepatitis C virus (HCV) and identification of HCV therapeuticsTRIPEP AB·Filed 2005·Granted Jul 28, 2009·4 cites·13 claims
- 2282US7534435B2Glycosylated specificity exchangersTRIPEP AB·Filed 2006·Granted May 19, 2009·4 cites·12 claims
- 2382US6455670B1Pentamer peptide amide, ALGPG-NH2, that inhibits viral infectivity and methods of use thereofTRIPEP AB·Filed 2001·Granted Sep 24, 2002·14 cites·21 claims
- 2481US7012129B2Antiviral composition comprising glycine amideTRIPEP AB·Filed 2003·Granted Mar 14, 2006·8 cites·19 claims
- 2577US7244715B2Vaccines containing ribavirin and methods of use thereofTRIPEP AB·Filed 2006·Granted Jul 17, 2007·1 cites·18 claims
- 2675US6258932B1Peptides that block viral infectivity and methods of use thereofTRIPEP AB·Filed 1999·Granted Jul 10, 2001·31 cites·33 claims
- 2771US7335359B2Glycosylated specificity exchangersTRIPEP AB·Filed 2004·Granted Feb 26, 2008·1 cites·16 claims
- 2869US2009170953A1Indentification of compounds that inhibit replication of human immunodeficiency virusTRIPEP AB·Filed 2007·Application pending·0 cites
- 2967US7244422B2Vaccines containing ribavirin and methods of use thereofTRIPEP AB·Filed 2006·Granted Jul 17, 2007·0 cites·12 claims
- 3065US2009305949A1Glycosylated specificity exchangerTRIPEP AB·Filed 2007·Application pending·0 cites
- 3163US7261883B2Vaccines containing ribavirin and methods of use thereofTRIPEP AB·Filed 2003·Granted Aug 28, 2007·0 cites·52 claims
- 3259US2009214593A1Immunogen platformTRIPEP AB·Filed 2009·Application pending·0 cites
- 3354US6537967B1Pentamer peptide amide, ALGPGNH2, which inhibits viral infectivity and methods of use thereofTRIPEP AB·Filed 2002·Granted Mar 25, 2003·0 cites·8 claims
- 3450US2009092631A1Glycosylated specificity exchangers that induce an antibody dependent cellular cytotoxicity (adcc) responseTRIPEP AB·Filed 2008·Application pending·0 cites
- 3547US6593455B2Tripeptide amides that block viral infectivity and methods of use thereofTRIPEP AB·Filed 2001·Granted Jul 15, 2003·0 cites·5 claims
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →